SILBER ALLAN C received a stock award from POINT BIOPHARMA GLOBAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 4 awards
Filed: 6/30/2021ACC: 0001104659-21-087833
Director
Since Jun 2021
+8.87M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
8.87M acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4.22M
Price / share
—
Trade value
—
% of position
New position
6/30/2021
0.00→4.22M
Common Stock
Indirect
Shares
+538.09K
Price / share
—
Trade value
—
% of position
New position
6/30/2021
0.00→538.09K
Common Stock
Indirect
Shares
+4.04M
Price / share
—
Trade value
—
% of position
New position
6/30/2021
0.00→4.04M
Common Stock
Indirect
Shares
+71.74K
Price / share
—
Trade value
—
% of position
New position
6/30/2021
0.00→71.74K
Total
Net shares
+8.86M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2021 | A · Award | +4.22M | — | — | New position | 0.00 | 4.22M |
| Common Stock Indirect | 6/30/2021 | A · Award | +538.09K | — | — | New position | 0.00 | 538.09K |
| Common Stock Indirect | 6/30/2021 | A · Award | +4.04M | — | — | New position | 0.00 | 4.04M |
| Common Stock Indirect | 6/30/2021 | A · Award | +71.74K | — | — | New position | 0.00 | 71.74K |
| Total | +8.86M | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
6.79K shares
Shares
+6.79K
Strike price
1.39
Held after
6.79K
Exercisable
—
6/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6.79K shares | 6/30/2021 | A · Award | +6.79K | 1.39 | — | 6.79K |